Lanzatech co-founder: we are missing out on the synthetic biology revolution

Lanzatech co-founder: we are missing out on the synthetic biology revolution
Dr Sean Simpson. (Image: Getty)
Peter Griffin
The third New Zealand-founded company in as many years is set to list on the Nasdaq.LanzaTech’s merger with “blank cheque” Nasdaq-listed company AMCI Acquisition Corp II sees it follow in the footsteps of Rocket Lab and footwear maker All Birds in taking the special purpose acquisition company (SPAC) route to become a publicly traded company.The deal, which values the merged company at around US$1.8 billion (NZ$2.8b), was cleared by shareholders on Tuesday. It confirms the Illinois-based LanzaTech’s status as our mo...

More Opinion

Surviving Trump's ‘whack-a-mole’ tariffs
Markets

Brian Robins: Surviving Trump's ‘whack-a-mole’ tariffs

Trump's end game is to curtail China's trade position.

Let the people hold the paintbrush
Policy He Poneketanga

Deb Te Kawa: Let the people hold the paintbrush

Central government works best when communities get a real say.

Deb Te Kawa 13 Jan 2025
BlackRock gives foreign investment a bad name
Opinion

Pattrick Smellie: BlackRock gives foreign investment a bad name

If it had set out to be disliked in NZ, BlackRock would be succeeding handsomely.

Pattrick Smellie 13 Jan 2025